Evidence map›Paper›PMID 26775130›Full record

ReviewSeminars in cell & developmental biology2016

Connexin channels in congenital skin disorders.

Evelyn Lilly, Caterina Sellitto, Leonard M Milstone, Thomas W White

Abstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Frontiers in cell and developmental biology · 2023
    Article
  18. Article
  19. Review
  20. A Quantitative Assay for CaInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Evelyn LillyDepartment of Dermatology, Yale School of Medicine, New Haven, CT 06510, USA.
Caterina SellittoDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.
Leonard M MilstoneDepartment of Dermatology, Yale School of Medicine, New Haven, CT 06510, USA.
Thomas W WhiteDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA. Electronic address: thomas.white@stonybrook.edu.
Stony Brook University · USYale University · US

Funding

Cx26 mutations in syndromic deafness linked to skin diseaseR01AR059505 · NIAMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI WHITE, THOMAS W · 2010 to 2014
$1.7M
NIAMS NIH HHS R01 AR059505NIAMS NIH HHS R01 AR59505
6 · The paper itself

Abstract

Gap junctions and hemichannels comprised of connexins influence epidermal proliferation and differentiation. Significant advances in our understanding of the functional role of connexins in the skin have been made by studying the diseases caused by connexin mutations. Eleven clinically defined cutaneous disorders with an overlapping spectrum of phenotypes are caused by mutations in five different connexin genes, highlighting that disease presentation must be deciphered with an understanding of how connexin functions are affected. Increasing evidence suggests that the skin diseases produced by connexin mutations result from dominant gains of function. In palmoplantar keratoderma with deafness, the connexin 26 mutations transdominantly alter the function of wild-type connexin 43 and create leaky heteromeric hemichannels. In keratitis-ichthyosis-deafness syndrome, different connexin 26 mutations can either form dominant hemichannels with altered calcium regulation or increased calcium permeability, leading to clinical subtypes of this syndrome. It is only with detailed understanding of these subtle functional differences that we can hope to create successful pathophysiology driven therapies for the connexin skin disorders.

Indexed as

AnimalsConnexinsEpidermisHumansMutationSkin DiseasesConnexinsConnexinEpidermisGap junctionGenetic diseaseHemichannelMutation

Identifiers

PMID26775130
PMCPMC4779425
OpenAlexW2232690243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.